Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses.

Pais R, Omosun Y, Igietseme JU, Fujihashi K, Eko FO. Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses. Front Immunol. 2019; 10:1577.

View in: PubMed

subject areas

Animals
Antibodies, Bacterial
Bacterial Proteins
Bacterial Vaccines
Chlamydia trachomatis
Female
fms-Like Tyrosine Kinase 3
Immunity, Mucosal
Immunoglobulin A
Lymphogranuloma Venereum
Mice
Porins
Th1 Cells
Th2 Cells
Vibrio cholerae

authors with profiles

Francis Eko
YUSUF OMOSUN

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support